Comparison of screening questionnaires for the diagnosis of hypogonadism
Three questionnaires, the St. Louis University Androgen Deficiency in Aging Male (ADAM), the Aging Male Survey (AMS) and the Massachusetts Male Aging Study (MMAS), have been developed as potential screening tools for hypogonadism in older males. We compared these questionnaires in 148 males aged 23–...
Gespeichert in:
| Veröffentlicht in: | Maturitas 2006-03, Vol.53 (4), p.424-429 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 429 |
|---|---|
| container_issue | 4 |
| container_start_page | 424 |
| container_title | Maturitas |
| container_volume | 53 |
| creator | Morley, John E. Perry, H.M. Kevorkian, R.T. Patrick, P. |
| description | Three questionnaires, the St. Louis University Androgen Deficiency in Aging Male (ADAM), the Aging Male Survey (AMS) and the Massachusetts Male Aging Study (MMAS), have been developed as potential screening tools for hypogonadism in older males. We compared these questionnaires in 148 males aged 23–80 years using bioavailable testosterone as the “biochemical gold standard” for diagnosis of hypogonadism. The sensitivity for the ADAM was 97%, for the AMS 83% and the MMAS 60%. Specificity was 30% for the ADAM, 59% for the MMAS and 39% for AMS. Both bioavailable testosterone and the calculated free testosterone correlated significantly with a number of the individual questions. Total testosterone correlated poorly with most of the questions. In conclusion, the ADAM and AMS may be useful screening tools for hypogonadism across the adult lifespan, but both are relatively nonspecific. |
| doi_str_mv | 10.1016/j.maturitas.2005.07.004 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67726248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378512205001829</els_id><sourcerecordid>67726248</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-1d95833876430c2ff0c8f314974d52e58714d35c68111954b5f64e7f3cbf096c3</originalsourceid><addsrcrecordid>eNqF0MtOAyEUgGFiNFovr6Cz0d2MMFxnaRpviYkbXRPKQKXpQOVMTXx7qW3s0hWb78DhR-iK4IZgIm4XzWDGdQ6jgabFmDdYNhizAzQhStKaEUIO0QRTqWpO2vYEnQIscIGYsmN0QgRhmCk2QU_TNKxMDpBilXwFNjsXQ5xXn2sHY0gxmpAdVD7lavxwVR_MPCYIsNEf36s0T9H0AYZzdOTNEtzF7jxD7w_3b9On-uX18Xl691JbJvhYk77jilIlBaPYtt5jqzwlrJOs563jShLWU26FKl_oOJtxL5iTntqZx52w9AzdbO9d5fS7ox4CWLdcmujSGrSQshUtUwXKLbQ5AWTn9SqHweRvTbDeRNQL_RdRbyJqLHWJWCYvd0-sZ4Pr93O7agVc74ABa5Y-m2gD7J0UpGsJL-5u61wJ8hVc1mCDi9b1pakddZ_Cv8v8ADtilFM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67726248</pqid></control><display><type>article</type><title>Comparison of screening questionnaires for the diagnosis of hypogonadism</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Morley, John E. ; Perry, H.M. ; Kevorkian, R.T. ; Patrick, P.</creator><creatorcontrib>Morley, John E. ; Perry, H.M. ; Kevorkian, R.T. ; Patrick, P.</creatorcontrib><description>Three questionnaires, the St. Louis University Androgen Deficiency in Aging Male (ADAM), the Aging Male Survey (AMS) and the Massachusetts Male Aging Study (MMAS), have been developed as potential screening tools for hypogonadism in older males. We compared these questionnaires in 148 males aged 23–80 years using bioavailable testosterone as the “biochemical gold standard” for diagnosis of hypogonadism. The sensitivity for the ADAM was 97%, for the AMS 83% and the MMAS 60%. Specificity was 30% for the ADAM, 59% for the MMAS and 39% for AMS. Both bioavailable testosterone and the calculated free testosterone correlated significantly with a number of the individual questions. Total testosterone correlated poorly with most of the questions. In conclusion, the ADAM and AMS may be useful screening tools for hypogonadism across the adult lifespan, but both are relatively nonspecific.</description><identifier>ISSN: 0378-5122</identifier><identifier>EISSN: 1873-4111</identifier><identifier>DOI: 10.1016/j.maturitas.2005.07.004</identifier><identifier>PMID: 16140484</identifier><identifier>CODEN: MATUDK</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Aging male ; Andropause ; Biological and medical sciences ; Biomarkers - blood ; Gynecology. Andrology. Obstetrics ; Humans ; Hypogonadism ; Hypogonadism - diagnosis ; Hypogonadism - physiopathology ; Male ; Medical sciences ; Middle Aged ; Puberal and climacteric disorders (male and female) ; Sensitivity and Specificity ; Surveys and Questionnaires ; Testosterone ; Testosterone - blood</subject><ispartof>Maturitas, 2006-03, Vol.53 (4), p.424-429</ispartof><rights>2005</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-1d95833876430c2ff0c8f314974d52e58714d35c68111954b5f64e7f3cbf096c3</citedby><cites>FETCH-LOGICAL-c465t-1d95833876430c2ff0c8f314974d52e58714d35c68111954b5f64e7f3cbf096c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.maturitas.2005.07.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17619215$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16140484$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morley, John E.</creatorcontrib><creatorcontrib>Perry, H.M.</creatorcontrib><creatorcontrib>Kevorkian, R.T.</creatorcontrib><creatorcontrib>Patrick, P.</creatorcontrib><title>Comparison of screening questionnaires for the diagnosis of hypogonadism</title><title>Maturitas</title><addtitle>Maturitas</addtitle><description>Three questionnaires, the St. Louis University Androgen Deficiency in Aging Male (ADAM), the Aging Male Survey (AMS) and the Massachusetts Male Aging Study (MMAS), have been developed as potential screening tools for hypogonadism in older males. We compared these questionnaires in 148 males aged 23–80 years using bioavailable testosterone as the “biochemical gold standard” for diagnosis of hypogonadism. The sensitivity for the ADAM was 97%, for the AMS 83% and the MMAS 60%. Specificity was 30% for the ADAM, 59% for the MMAS and 39% for AMS. Both bioavailable testosterone and the calculated free testosterone correlated significantly with a number of the individual questions. Total testosterone correlated poorly with most of the questions. In conclusion, the ADAM and AMS may be useful screening tools for hypogonadism across the adult lifespan, but both are relatively nonspecific.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aging male</subject><subject>Andropause</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Hypogonadism</subject><subject>Hypogonadism - diagnosis</subject><subject>Hypogonadism - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Puberal and climacteric disorders (male and female)</subject><subject>Sensitivity and Specificity</subject><subject>Surveys and Questionnaires</subject><subject>Testosterone</subject><subject>Testosterone - blood</subject><issn>0378-5122</issn><issn>1873-4111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0MtOAyEUgGFiNFovr6Cz0d2MMFxnaRpviYkbXRPKQKXpQOVMTXx7qW3s0hWb78DhR-iK4IZgIm4XzWDGdQ6jgabFmDdYNhizAzQhStKaEUIO0QRTqWpO2vYEnQIscIGYsmN0QgRhmCk2QU_TNKxMDpBilXwFNjsXQ5xXn2sHY0gxmpAdVD7lavxwVR_MPCYIsNEf36s0T9H0AYZzdOTNEtzF7jxD7w_3b9On-uX18Xl691JbJvhYk77jilIlBaPYtt5jqzwlrJOs563jShLWU26FKl_oOJtxL5iTntqZx52w9AzdbO9d5fS7ox4CWLdcmujSGrSQshUtUwXKLbQ5AWTn9SqHweRvTbDeRNQL_RdRbyJqLHWJWCYvd0-sZ4Pr93O7agVc74ABa5Y-m2gD7J0UpGsJL-5u61wJ8hVc1mCDi9b1pakddZ_Cv8v8ADtilFM</recordid><startdate>20060320</startdate><enddate>20060320</enddate><creator>Morley, John E.</creator><creator>Perry, H.M.</creator><creator>Kevorkian, R.T.</creator><creator>Patrick, P.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060320</creationdate><title>Comparison of screening questionnaires for the diagnosis of hypogonadism</title><author>Morley, John E. ; Perry, H.M. ; Kevorkian, R.T. ; Patrick, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-1d95833876430c2ff0c8f314974d52e58714d35c68111954b5f64e7f3cbf096c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aging male</topic><topic>Andropause</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Hypogonadism</topic><topic>Hypogonadism - diagnosis</topic><topic>Hypogonadism - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Puberal and climacteric disorders (male and female)</topic><topic>Sensitivity and Specificity</topic><topic>Surveys and Questionnaires</topic><topic>Testosterone</topic><topic>Testosterone - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morley, John E.</creatorcontrib><creatorcontrib>Perry, H.M.</creatorcontrib><creatorcontrib>Kevorkian, R.T.</creatorcontrib><creatorcontrib>Patrick, P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Maturitas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morley, John E.</au><au>Perry, H.M.</au><au>Kevorkian, R.T.</au><au>Patrick, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of screening questionnaires for the diagnosis of hypogonadism</atitle><jtitle>Maturitas</jtitle><addtitle>Maturitas</addtitle><date>2006-03-20</date><risdate>2006</risdate><volume>53</volume><issue>4</issue><spage>424</spage><epage>429</epage><pages>424-429</pages><issn>0378-5122</issn><eissn>1873-4111</eissn><coden>MATUDK</coden><abstract>Three questionnaires, the St. Louis University Androgen Deficiency in Aging Male (ADAM), the Aging Male Survey (AMS) and the Massachusetts Male Aging Study (MMAS), have been developed as potential screening tools for hypogonadism in older males. We compared these questionnaires in 148 males aged 23–80 years using bioavailable testosterone as the “biochemical gold standard” for diagnosis of hypogonadism. The sensitivity for the ADAM was 97%, for the AMS 83% and the MMAS 60%. Specificity was 30% for the ADAM, 59% for the MMAS and 39% for AMS. Both bioavailable testosterone and the calculated free testosterone correlated significantly with a number of the individual questions. Total testosterone correlated poorly with most of the questions. In conclusion, the ADAM and AMS may be useful screening tools for hypogonadism across the adult lifespan, but both are relatively nonspecific.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>16140484</pmid><doi>10.1016/j.maturitas.2005.07.004</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0378-5122 |
| ispartof | Maturitas, 2006-03, Vol.53 (4), p.424-429 |
| issn | 0378-5122 1873-4111 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67726248 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adult Aged Aged, 80 and over Aging male Andropause Biological and medical sciences Biomarkers - blood Gynecology. Andrology. Obstetrics Humans Hypogonadism Hypogonadism - diagnosis Hypogonadism - physiopathology Male Medical sciences Middle Aged Puberal and climacteric disorders (male and female) Sensitivity and Specificity Surveys and Questionnaires Testosterone Testosterone - blood |
| title | Comparison of screening questionnaires for the diagnosis of hypogonadism |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T15%3A37%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20screening%20questionnaires%20for%20the%20diagnosis%20of%20hypogonadism&rft.jtitle=Maturitas&rft.au=Morley,%20John%20E.&rft.date=2006-03-20&rft.volume=53&rft.issue=4&rft.spage=424&rft.epage=429&rft.pages=424-429&rft.issn=0378-5122&rft.eissn=1873-4111&rft.coden=MATUDK&rft_id=info:doi/10.1016/j.maturitas.2005.07.004&rft_dat=%3Cproquest_cross%3E67726248%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67726248&rft_id=info:pmid/16140484&rft_els_id=S0378512205001829&rfr_iscdi=true |